Lactic acidosis after treatment with linezolid

M. Wiener; Y. Guo; G. Patel; B. C. Fries

doi:10.1007/s15010-007-6302-x

Lactic acidosis after treatment with linezolid

M. Wiener
, Y. Guo
, G. Patel
, B. C. Fries

Research output: Contribution to journal › Review article › peer-review

39 Scopus citations

Abstract

Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.

Original language	English
Pages (from-to)	278-281
Number of pages	4
Journal	Infection
Volume	35
Issue number	4
DOIs	https://doi.org/10.1007/s15010-007-6302-x
State	Published - Aug 2007

Access to Document

10.1007/s15010-007-6302-x

Cite this

@article{b7313767155740ab9d9497a30d969d76,

title = "Lactic acidosis after treatment with linezolid",

abstract = "Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.",

author = "M. Wiener and Y. Guo and G. Patel and Fries, \{B. C.\}",

year = "2007",

month = aug,

doi = "10.1007/s15010-007-6302-x",

language = "English",

volume = "35",

pages = "278--281",

journal = "Infection",

issn = "0300-8126",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

TY - JOUR

T1 - Lactic acidosis after treatment with linezolid

AU - Wiener, M.

AU - Guo, Y.

AU - Patel, G.

AU - Fries, B. C.

PY - 2007/8

Y1 - 2007/8

N2 - Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.

AB - Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.

UR - https://www.scopus.com/pages/publications/34547666898

U2 - 10.1007/s15010-007-6302-x

DO - 10.1007/s15010-007-6302-x

M3 - Review article

C2 - 17646908

AN - SCOPUS:34547666898

SN - 0300-8126

VL - 35

SP - 278

EP - 281

JO - Infection

JF - Infection

IS - 4

ER -

Lactic acidosis after treatment with linezolid

Abstract

Access to Document

Fingerprint

Cite this